MLND - Millendo Therapeutics EPS beats by $0.07 August, 12 2019 07:33 AM Millendo Therapeutics Millendo Therapeutics (NASDAQ:MLND): Q2 GAAP EPS of -$0.74 beats by $0.07.Cash, cash equivalents, marketable securities and restricted cash of $56.63MPress ReleaseMore news on: Millendo Therapeutics, Inc., Earnings news and commentary, ,